Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Octapharma AB
FDA Inspection
•Octapharma AB•September 19, 2023

Octapharma AB – FDA Inspection, Sep 19, 2023

Record Details

This FDA Inspection record concerns Octapharma AB, with an inspection on September 19, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Octapharma AB
Inspection Date
September 19, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Alan L. Truong
  • Olga Simakova (Issuing Officer)
  • Scott T. Ballard (FDA Associated Person)
  • Ze Peng (Issuing Officer)
View Company Profile

ID · 3645f477-d675-40fc-90b8-3704a595408d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1218250
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.110(a)Written in-process control procedures
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  4. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  5. 21 CFR 211.110(a)Written in-process control procedures
  6. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Octapharma AB

6
DateClassificationOfficeProject area
September 28, 2018VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
October 3, 2016Not classifiedOffice of Inspections and Investigations
April 28, 2014VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
January 19, 2012VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
January 20, 2011OAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 6 other inspections on the company page
Other documents for Octapharma AB
  • FDA Inspection 1070173 - 2018-09-28
  • FDA Inspection 994537 - 2016-10-03
  • FDA Inspection 894095 - 2014-04-28
  • FDA Inspection 783783 - 2012-01-19
  • FDA Inspection 710676 - 2011-01-20

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Octapharma AB
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.